Elevated Lp(a) is associated with an increased risk of major adverse cardiovascular events (MACE) independently of hs-CRP level in both primary and secondary prevention populations. This is the conclusion from a systematic review and meta analysis of data from 11 studies, involving 562,301 participants, that reported the relationship between Lp(a) and MACE, stratified by hs-CRP level.
